Company History

1980s
Salisbury site acquired in 1983 by F H Faulding & Co Limited.
Development of delayed-release doxycycline capsules (DORYX®).
Development of enteric coated aspirin (ASTRIX®).
WF Scammell Research Centre opened at Salisbury.

1990s
Development of taste-masking technology (CLEANTASTE®).
Development of sustained-release morphine (KADIAN® / KAPANOL®).
Metrics founded as a contract testing company in Greenville, North Carolina.

2000s
Development of improved bioavailability technology (SUBA™).
Development of pellet-in-a-tablet technology (DORYX®).
Development of LOZANOC®/TOLSURA® improved formulation of itraconazole.
